Anbio Biotechnology (NNNN) Total Liabilities (2023 - 2024)

Historic Total Liabilities for Anbio Biotechnology (NNNN) over the last 3 years, with Q2 2025 value amounting to $131.1 billion.

  • Anbio Biotechnology's Total Liabilities changed N/A to $131.1 billion in Q2 2025 from the same period last year, while for Jun 2025 it was $131.1 billion, marking a year-over-year change of. This contributed to the annual value of $1.7 million for FY2024, which is 7423.26% up from last year.
  • Anbio Biotechnology's Total Liabilities amounted to $131.1 billion in Q2 2025.
  • Anbio Biotechnology's Total Liabilities' 5-year high stood at $131.1 billion during Q2 2025, with a 5-year trough of $993060.0 in Q4 2023.
  • Its 3-year average for Total Liabilities is $43.7 billion, with a median of $1.7 million in 2024.
  • The largest annual percentage gain for Anbio Biotechnology's Total Liabilities in the last 5 years was 7423.26% (2024), contrasted with its biggest fall of 7423.26% (2024).
  • Anbio Biotechnology's Total Liabilities (Quarter) stood at $993060.0 in 2023, then surged by 74.23% to $1.7 million in 2024, then soared by 7578470.3% to $131.1 billion in 2025.
  • Its last three reported values are $131.1 billion in Q2 2025, $1.7 million for Q4 2024, and $993060.0 during Q4 2023.